Insights / Research Brief•May 10, 2022
Does Entry Remedy Collusion? Evidence From the Generic Prescription Drug Cartel
In April 2013, Teva Pharmaceuticals, a large generic drug manufacturer, hired a marketing executive with strong connections throughout the industry with the goal of exploring opportunities to increase profits. Or, in that marketing executive’s own words, to enact “price increase implementation.”
Topics:
Health care, Industrial Organization
Insights / Podcast episode•Mar 25, 2021
Incentives and the Race to Vaccinate
Eduardo Porter, Tess Vigeland, Joshua Gottlieb, David Pitrak
With COVID-19 variants proliferating, administering vaccines as quickly as possible is a key policy priority....
Topics:
Health care, COVID-19
Insights / Video
Watch: Preparing for a Pandemic: Accelerating Vaccine Availability
Read Unedited Transcript In a new working paper, Preparing for a Pandemic: Accelerating Vaccine...
Topics:
COVID-19, Health care
Insights / Podcast episode•Dec 17, 2020
A Vaccine for Billions
Eduardo Porter, Tess Vigeland, Michael Kremer, Canice Prendergast
The economic benefits of ending the COVID-19 pandemic even one day earlier are enormous. Michael...
Topics:
COVID-19, Health care
Insights / Podcast episode•Dec 03, 2020
Pre-existing Confusion: The US Health Insurance System
Eduardo Porter, Tess Vigeland, Katherine Baicker, Matthew J. Notowidigdo, Stacy Lindau
The American health insurance system is complex, politically divisive, in need of reform, and facing...
Topics:
Health care, COVID-19
Insights / Podcast episode•Oct 08, 2020
Deep Dive Series – The Health Care Conundrum, Part 2
Eduardo Porter, Tess Vigeland, Katherine Baicker, Stacy Lindau, Neale Mahoney, David Meltzer, Kenneth Polonsky
The US pays roughly twice as much per person for healthcare as other wealthy nations....
Topics:
COVID-19, Health care
Insights / Podcast episode•Sep 24, 2020
Deep Dive Series – The Health Care Conundrum, Part 1
Eduardo Porter, Tess Vigeland, Katherine Baicker, Pietro Tebaldi
The global pandemic has revealed critical gaps and weaknesses in the US health care system....
Topics:
COVID-19, Health care
Insights / Podcast episode•Jul 30, 2020
Episode 16: How to Price a Vaccine?
Eduardo Porter, Tess Vigeland, Katherine Baicker, Richard Thaler
Under both pandemic and economic stress, how will the market perform when it comes to...
Topics:
COVID-19, Health care